Qiumeng Liu

Tongji Medical College

H指数:18

被引数:981

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma

靶向FAM134B-DDX3X轴抑制肝细胞癌中的AKT信号通路

Cell Death & Disease

IF9.6

2025-11-060

OAAI

Erratum to: Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study

勘误：尾状叶切除是否真的改善了肝门部胆管癌患者的手术效果？一项多中心回顾性研究

science china life sciences

IF0

2025-08-080

PREAI

Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti–PD-1 resistance in hepatocellular carcinoma

Riplet促进肝细胞癌中与CD8 T细胞耗竭和anti-PD-1抵抗相关的脂质代谢变化

Science Immunology

IF16.3

2025-06-270

PRE

Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study

尾状叶切除是否真的能改善肝门部胆管癌患者的手术结局？一项多中心回顾性研究

SCIENCE CHINA-LIFE SCIENCES

IF9.5

2025-03-270

PRE

TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway

TGM2介导的组蛋白血清素化通过MYC信号通路促进HCC进展

Journal of Hepatology

IF33

2025-01-070

PRE

CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression

AUTOPHAGY

IF14.3

2024-12-170

PRE

N6-methyladenosine modification of circular RNA circASH2L suppresses growth and metastasis in hepatocellular carcinoma through regulating hsa-miR-525-3p/MTUS2 axis

环状RNA circASH2L的N6-methyladenosine修饰通过调节hsa-miR-525-3p/MTUS2轴抑制肝细胞癌的生长和转移

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2024-11-140

OAAI

CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38

MEDCOMM

IF10.7

2024-07-010

Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-04-012

OAAI

YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA Axis

ADVANCED SCIENCE

IF14.1

2024-01-2113

USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma

ONCOGENE

IF7.3

2023-11-163

PRE

Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5p

ADVANCED SCIENCE

IF14.1

2023-04-2516

Effects of Biological Nitrification Inhibitor on Nitrous Oxide and nosZ, nirK, nirS Denitrifying Bacteria in Paddy Soils

SUSTAINABILITY

IF3.3

2023-03-178

Strategies for indica rice adapted to high-temperature stress in the middle and lower reaches of the Yangtze River

FRONTIERS IN PLANT SCIENCE

IF4.8

2023-01-068

OAAI

MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma

ONCOGENE

IF7.3

2022-11-178

PRE

DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6

ONCOGENE

IF7.3

2022-02-0925

OAAI

Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway

CELLULAR ONCOLOGY

IF4.8

2022-01-2820

PRE

The crosstalk network of XIST/miR-424-5p/OGT mediates RAF1 glycosylation and participates in the progression of liver cancer

LIVER INTERNATIONAL

IF5.2

2021-05-2819

PREAI

The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway

THERANOSTICS

IF13.3

2021-01-0155

OAAI

PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-β Receptor 1

HEPATOLOGY

IF15.8

2020-09-0335

PREAI

Qiumeng Liu

个人简介

教育背景

工作经历

荣誉奖项

研究方向